Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

Wei He, Yan Zhang, Yu Xiong, Feng-juan Dai, Qing-xia Fan The Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China Background: The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors have been s...

Full description

Bibliographic Details
Main Authors: He W, Zhang Y, Xiong Y, Dai FJ, Fan QX
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:OncoTargets and Therapy
Subjects:
icotinib
docetaxel
second-line therapy
lung adenocarcinoma
EGFR-TKIs
Online Access:https://www.dovepress.com/icotinib-versus-docetaxel-used-in-lung-adenocarcinoma-patients-who-fai-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/icotinib-versus-docetaxel-used-in-lung-adenocarcinoma-patients-who-fai-peer-reviewed-article-OTT

Similar Items